Close Menu

NEW YORK – Thermo Fisher Scientific said on Wednesday that it has a signed a companion diagnostic agreement with Chugai Pharmaceutical, a member of the Roche group.

In addition, Thermo Fisher has applied to the Ministry of Health, Labor, and Welfare of Japan to expand the use of the Oncomine Dx Target test in that country.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.